Lawyer Seek Logo
Lawyer Seek Logo - Gadolinium Contrast Agents

Gadolinium Contrast Agents Facts:


Gadolinium-Based Contrast Agents:

Magnevist (Gadopentetate Dimeglumine)
MultiHance (Gadobenate Dimeglumine)
Omniscan (Gadodiamide)
OptiMARK (Gadoversetamide)
ProHance (Gadoteridol)

Potential Adverse Effects / Potential Injuries:

NSF/NFD
Burning, Itching, or Swelling
Deep Pain in the Hip Bones or Ribs
Difficulty Bending Joints
Difficulty Moving or Straightening Arms, Hands, Legs or Feet
Muscle Weakness
Red or Dark Skin Patches
Tight Rigid Skin
Yellow, Raised Spots on the Whites of Eyes

Common Misspellings:

Gadolenium
Gadollinium

Regions of Practice:

New York
New Jersey
Pennsylvania
Nationwide
Martindale Hubbell Peer Review Rated Lawyer Logo

Martindale Hubbell AV Lawyer Logo

National Law Journal The Plaintiffs Hot List

Gadolinium Contrast Agents
Email Gadolinium Contrast Agents Button
 Print Gadolinium Contrast Agents Button

FDA Issues Public Health Advisory Concerning Gadolinium-Based Contrast Agents


In December 2006 the Food and Drug Administration (FDA) issued a second and stronger Public Health Advisory concerning a link between certain contrast agents, used during Magnetic Resonance Imaging (MRI) and Magnetic Resonance Angiography (MRA) procedures, and a debilitating and potentially fatal skin disorder known as Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy (NSF/NFD). Since it released its first Public Health Advisory in June 2006, the FDA has been further investigating the apparent relationship between contrast agents containing gadolinium and NSF/NFD. As of this past December, the FDA had received reports of 90 patients that developed NSF/NFD within 2 days to 18 months after after exposure to such contrast agents.
The FDA asks physicians to consider the risks of using gadolinium-based contrast agents in patients with moderate to end-stage kidney disease and advises patients to contact a doctor right away if they experience any of the symptoms of NSF/NFD.

Contact us regarding Gadolinium Contrast Agents; attorney consultations are free.

What is Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy (NSF/NFD)?


NSF/NFD occurs in individuals who have moderate to end-stage kidney disease. It is characterized by areas of tight, rigid skin and difficulty bending joints and can also result in fibrosis and the scarring of body organs. Signs of NSF/NFD also include: burning; itching; swelling; red or dark patches on the skin; difficulty moving or straightening arms, hands, legs or feet; yellow, raised spots on the whites of eyes; deep pain in the hip bones or ribs; and muscle weakness.

What is a Gadolinium-Based Contrast Agent?


An MRI is a detailed picture of a patient’s internal organs and tissues, while an MRA is a used to take a detailed picture of a patient’s blood vessels. During some MRI and MRA scans, a gadolinium-based contrast agent may be injected into a patient’s blood vessels in order to distinguish them from other tissues. However, not all contrast agents used for this purpose contain gadolinium. The five trade names for FDA approved gadolinium-based agents are Omniscan, OptiMARK, Magnevist, ProHance and MultiHance.

Questions and Consultations


If you or someone you know suffers from moderate to end-stage kidney disease and developed NSF/NFD following an MRI or MRA, and you would like to discuss your rights, please complete our brief evaluation form. A member of Seeger Weiss LLP's experienced staff will call you to discuss your potential claim. Attorney consultations incur no obligation on your part and all initial consultations are free of charge and do not create an attorney-client relationship. Seeger Weiss LLP has office locations in both New York and New Jersey and its attorneys practice in courts throughout the country.

Link To Lawyer Seek's Gadolinium Contrast Agents Content:
<a href='http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Gadolinium-Based-Contrast-Agents-P156/'>Gadolinium Contrast Agents: Lawyer Seek</a>

Gadolinium Contrast Agents lawyer consultation at no cost
Name :
Email :
Phone :
 
Search Menu
Advanced Search
Topics
Other Resources
Other Resources
» Fosamax
» Advair
» Ortho Evra
» Accutane
» Asbestos
HomePractice AreasAttorneysFirm ProfileNewsContact UsSite MapDisclaimer
© 2008 Seeger Weiss LLP. All rights reserved. Statement of Clients' Rights: Please note that you are not considered our client unless you have signed a retainer agreement and your case has been accepted.Prior results do not guarantee or predict a similar outcome with respect to any future matter.1 William Street, New York, NY, 10004. Attorney Advertising.